Sundheds- og Ældreudvalget 2019-20
SUU Alm.del
Offentligt
2181651_0001.png
Member State Questionnaire on the Assessment of
the Tobacco Products Directive
1.1
Introduction
ICF is currently undertaking a study on Directive 2014/40/EU of the European Parliament
and of the Council of 3 April 2014 on the approximation of the laws, regulations and
administrative provisions of the Member States concerning the manufacture, presentation
and sale of tobacco and related products and repealing Directive 2001/37/EC (revised
Tobacco Products Directive)
on behalf of the Directorate-General for Health and Food
Safety of the European Commission (DG SANTE).
The purpose of the study is to examine the practical application of Directive 2014/40/EU
(hereinafter TPD) and its specific provisions, which strengthened existing rules on how
tobacco products are manufactured, produced and presented in the EU, and introduced new
rules for certain tobacco-related products. The study will assess the level of implementation
of the TPD by exploring both achievements and hindering factors.
In particular, the study aims to:
Assess its implementation and levels of compliance: exploring the achievements
and successes of the revised Directive, as well as obstacles and shortcomings
encountered by various stakeholders (Member States, Civil Society
Organisations, health experts, and economic operators);
Generate evidence (through primary and secondary data collection) - in
particular on the inputs, outputs, outcomes and impacts of the TPD, with the aim
to assess its overall relevance, effectiveness, efficiency, coherence and EU-
added value.
The study will be used by the Commission for the preparation of its report on the application
of the TPD, required by Article 28 of the Directive.
1.2
Purpose of consultation
The purpose of the consultation is to collect information and gather views from relevant
authorities of EU Member States bound by the Directive on its implementation. We
encourage you to elaborate on your replies and provide references to publicly accessible
studies, surveys, court cases or any other documentation that you consider relevant.
If you have any questions with regard to the study, please do not hesitate to contact the
project manager of the study: Christina Dziewanska-Stringer,
[email protected]
.
1.3
Your details
Table 1.1 Respondent's details
Country
Name(s)
Email(s)
Contact number
1
1
SUU, Alm.del - 2019-20 - Endeligt svar på spørgsmål 804: Spm. om oversendelse af det spørgeskema, som EU-Kommissionen har sendt til medlemsstaterne med henblik på en evaluering af tobaksvaredirektivet, til sundheds- og ældreministeren
2181651_0002.png
1.4
1.4.1
Questions on general implementation
Effectiveness
This series of questions asks about your views on how successful the TPD has been in achieving or supporting progress towards its objectives,
including facilitating the smooth functioning of the internal market and ensuring a high level of human health protection, since it entered into force on
19 May 2014.
Question
Has your Member State faced any issues in
transposing the TPD?
Did you find the guidance received from the
Commission on transposing the TPD (for
example, through discussions at Expert
Groups, Sub-Groups or guidance documents)
clear and useful?
Member State response
Yes / No / To some extent.
Please elaborate, for example, any issues with specific articles.
Yes / No / To some extent.
Please elaborate.
Overall, have economic operators been
compliant with the TPD in your Member
State?
Has the TPD achieved its objectives, i.e.
improved the functioning of the internal
market while reducing smoking prevalence?
In your view, has the TPD improved public
health in your Member State (e.g. increased
awareness of the harmfulness of products;
decreased smoking rates)?
Does your Member State collect national data
on the level of prevalence of use in the under
25 years of age consumer group?
Has the TPD changed tobacco and related
product use in young people in your Member
State?
Yes / No / To some extent.
Please elaborate.
Yes / No / To some extent.
Please elaborate.
Yes / No / To some extent.
Please elaborate, including any relevant provisions.
Yes / No.
If yes, please provide the most recent results (web link or attachment)
Yes: it has increased use;
Yes: it has decreased use;
No: it has not changed use.
Please elaborate.
1
2
SUU, Alm.del - 2019-20 - Endeligt svar på spørgsmål 804: Spm. om oversendelse af det spørgeskema, som EU-Kommissionen har sendt til medlemsstaterne med henblik på en evaluering af tobaksvaredirektivet, til sundheds- og ældreministeren
2181651_0003.png
1.4.2
Relevance
For the next set of questions, we would like to ask you about the extent to which the TPD and its objectives are still relevant and meeting needs,
considering scientific, technical and epidemiological developments. We are interested in if the TPD is flexible and has the capacity to evolve to
withstand developments in the sector.
Question
In your view, has the TPD remained relevant
to address new market developments in your
Member State, including types of emerging
products? (For example, heated tobacco
products or nicotine containing products).
Member State response
Yes / No / To some extent.
Please elaborate.
In your view, is the TPD ‘future proof’, as new
Yes / No / To some extent.
societal, technical and scientific developments
Please elaborate.
occur in the sector?
2
3
SUU, Alm.del - 2019-20 - Endeligt svar på spørgsmål 804: Spm. om oversendelse af det spørgeskema, som EU-Kommissionen har sendt til medlemsstaterne med henblik på en evaluering af tobaksvaredirektivet, til sundheds- og ældreministeren
2181651_0004.png
1.4.3
Efficiency
Questions in this sub-section concern your views on the administrative burdens imposed by the TPD and their magnitude in relation to the benefits
generated.
Question
Has the practical implementation of the TPD
created significant additional administrative
burdens in your Member State?
Member State response
Yes / No / To some extent.
Please elaborate.
Would you consider that the benefits the TPD
Yes / No / To some extent.
brings to consumers outweigh the overall
Please elaborate.
costs that are being incurred to implement the
Directive? To what extent were you able to
recover some of the costs incurred via fees?
Has your Member State provided any specific
support to small and medium enterprises
affected by the TPD?
Yes / No / To some extent.
Please elaborate.
1.4.4
Coherence
For the next set of questions, we are interested in your thoughts on the extent to which the TPD is still coherent and consistent internally, i.e. with its
own provisions, as well as with other relevant EU and international legislation that is linked to the TPD.
Question
Member State response
Has your Member State faced any issues with
Yes / No / To some extent.
TPD provisions being inconsistent or
Please elaborate.
incoherent with each other? For example,
have the requirements of one article
contradicted the requirements of another?
Has your Member States faced any issues
with TPD provisions being inconsistent or
incoherent with other EU legislation, for
example:
The Tobacco Taxation Directive
3
4
SUU, Alm.del - 2019-20 - Endeligt svar på spørgsmål 804: Spm. om oversendelse af det spørgeskema, som EU-Kommissionen har sendt til medlemsstaterne med henblik på en evaluering af tobaksvaredirektivet, til sundheds- og ældreministeren
2181651_0005.png
Question
The audio-visual media services
Directive
Tobacco Advertising Directive
Smoke Free Environments
recommendation
Single Use Plastics Directive
Market Surveillance Regulation
The CLP Regulation for
(Classification, Labelling and
Packaging)
General Product Safety Directive
REACH (Regulation (EC) No
1907/2006)
Member State response
Has your Member State faced any issues with
Yes / No / To some extent.
TPD provisions being inconsistent or
Please elaborate.
incoherent with FCTC guidelines, including
the
Protocol to Eliminate Illicit Trade in
Tobacco Products?
1.4.5
EU added value
The final few questions are about your views on the extent to which the TPD adds value at the EU level, in a way that may not be attainable at a
national or global level.
Question
Has the TPD added value to the regulation of
tobacco and tobacco-related products across
the EU?
Do you feel that the effects of the TPD on
smoking consumption or the illicit trade could
have been achieved at the level of your
Member State, without EU-level involvement?
Member State response
Yes / No / To some extent.
Please elaborate
Yes / No / To some extent.
Please elaborate
4
5
SUU, Alm.del - 2019-20 - Endeligt svar på spørgsmål 804: Spm. om oversendelse af det spørgeskema, som EU-Kommissionen har sendt til medlemsstaterne med henblik på en evaluering af tobaksvaredirektivet, til sundheds- og ældreministeren
2181651_0006.png
1.5
1.5.1
Questions by article of interest
Article 2: Definitions
Member State response
Background
Question
and key
considerations
The directive sets
out 41 definitions to
be applied.
Clear definitions are
indispensable to
ensure that this
Directive is
uniformly
implemented by
Member States.
Have the definitions in the TPD been
clear and unambiguous enough to
allow for clear interpretation and
implementation?
Yes / No / Some unclarities and ambiguities.
Please elaborate: If you consider one or more definitions to be unclear and/or ambiguous, please describe them here and propose improvements.
For example, definitions including (but
not limited to):
- Novel Tobacco Products
- Electronic cigarettes
- Refill containers
- Roll your own tobacco
However, certain
- Additive
concepts - defined
- Nicotine
within this Directive-
- Chewing, nasal and oral tobacco
may remain
Retail Outlet
unclear, and cause
- Flavouring
interpretation
- Substantial change of circumstances
issues, and/or
- Flavour/flavouring
divergent
- Characterising flavour
interpretations,
- Cross border distance sales
during
Have you experienced any particular
implementation.
issues with the classification of
products, based on how they are
Also, in the light of
defined in the Directive (e.g.
various scientific,
“smokeless tobacco products” versus
technological and
“tobacco products for smoking”)?
market
Have the definitions laid out in the
developments,
some of the current
TPD remained relevant in view of
scientific, technological and market
definitions may no
developments?
Yes / No / To some extent.
Please elaborate.
Yes / No / To some extent.
Please elaborate: If you consider one or more definition to be irrelevant in view of scientific, technological and market developments, please describe them
here.
5
6
SUU, Alm.del - 2019-20 - Endeligt svar på spørgsmål 804: Spm. om oversendelse af det spørgeskema, som EU-Kommissionen har sendt til medlemsstaterne med henblik på en evaluering af tobaksvaredirektivet, til sundheds- og ældreministeren
2181651_0007.png
Background
Question
and key
considerations
longer be relevant
or appropriate.
*Please refer to
Article 2 of the TPD
for the full list.
Are there any other products or
categories for which a definition
should be included in the Directive?
Are the concepts as defined in this
Directive consistent with other EU
legislative instruments (e.g. Tobacco
Taxation Directive, Tobacco
Advertising Directive, Audio-visual
Media Services Directive) or other
legislation at National level?
Has your Member State encountered
any other difficulties in the practical
application of the provisions of this
Article?
Member State response
Yes / No.
Please elaborate.
Yes / No / To some extent.
Please elaborate: have inconsistencies led to any implementation issues in practice?
Yes / No / To some extent.
Please elaborate, including specifying the provisions of difficulty.
Please use this space for further explanation of any of the responses above, AND / OR any other observations you would like to share related to Article 2.
1.5.2
Article 3: Maximum emission levels for tar, nicotine, carbon monoxide and other substances
Member State response
Background
Question
and key
considerations
6
7
SUU, Alm.del - 2019-20 - Endeligt svar på spørgsmål 804: Spm. om oversendelse af det spørgeskema, som EU-Kommissionen har sendt til medlemsstaterne med henblik på en evaluering af tobaksvaredirektivet, til sundheds- og ældreministeren
2181651_0008.png
The TPD sets
maximum emission
levels from
cigarettes placed on
the market or
manufactured in the
Member States for
tar, nicotine, and
carbon monoxide.
If Member States
set additional
maximum emission
levels for cigarettes,
they must inform
the commission.
In view of new
technical and
scientific
developments,
these may be no
longer or less
relevant.
Are the provisions on maximum
TNCO emissions (Article 3(1)) still
relevant in view of scientific and
technological developments?
Has your Member State set limits for
additional maximum emission levels
for cigarettes (Article 3(3))?
Has your Member State set limits for
maximum emission levels for other
tobacco products (Article 3(3))?
Has your Member State encountered
any other difficulties in the practical
application of the provisions of this
Article?
Yes / No / To some extent.
Please elaborate: Is there scope or necessity for changing the TNCO limits or introducing other limits?
Yes / No.
If no: are you considering it? Why or why not?
If yes: Please elaborate, including when the Commission was notified.
Yes / No.
If no: are you considering it? Why or why not?
If yes: Please elaborate, including when the Commission was notified.
Yes / No / To some extent.
Please elaborate, including specifying the provisions of difficulty.
Please use this space for further explanation of any of the responses above, AND / OR any other observations you would like to share related to Article 3.
7
8
SUU, Alm.del - 2019-20 - Endeligt svar på spørgsmål 804: Spm. om oversendelse af det spørgeskema, som EU-Kommissionen har sendt til medlemsstaterne med henblik på en evaluering af tobaksvaredirektivet, til sundheds- og ældreministeren
2181651_0009.png
1.5.3
Article 4: Measurement methods
Member State response
Background
Question
and key
considerations
The TPD sets the
measurement
methods using ISO
standards for tar,
nicotine, and
carbon monoxide
for cigarettes
placed on the
market or
manufactured in the
Member States.
The measurements
must be verified by
independent
approved
laboratories.
In view of new
technical and
scientific
developments,
these measurement
methods may be no
longer relevant, in
which case
delegated acts are
foreseen by this
directive.
Are provisions on measurement
methods (Article 4(1)) still relevant
in view of scientific and
technological developments?
Yes / No / To some extent.
Please elaborate.
Would there be necessity or scope
Yes / No / To some extent.
for changing the measurement
Please elaborate.
methods for emissions from the ISO
method to e.g. the Canadian Intense
(CI) method?
Has your Member State faced any
issues with regard to the
appointment and monitoring of
laboratories (Article 4(2))? For
example, in ensuring these are fully
independent from the tobacco
industry?
Has your Member State used any
measurement methods for
emissions for cigarettes other than
the three specified in Article 4(1)
(Article 4(4))?
Has your Member State used any
measurement methods for
emissions for other tobacco
products (Article 4(4))?
Has your Member State charged
manufacturers and importers of
tobacco products proportionate fees
for the verification of these
measurement methods (Article
4(6))?
Yes / No / To some extent.
Please elaborate.
How many laboratories have you approved to date? If none, what laboratories do you use for verification?
Yes / No.
If no: are you considering it? Why or why not?
If yes: Please elaborate, including when the Commission was notified.
Yes / No.
If no: are you considering it? Why or why not?
If yes: Please elaborate, including when the Commission was notified.
Yes / No.
If no: are you considering it? Why or why not?
8
9
SUU, Alm.del - 2019-20 - Endeligt svar på spørgsmål 804: Spm. om oversendelse af det spørgeskema, som EU-Kommissionen har sendt til medlemsstaterne med henblik på en evaluering af tobaksvaredirektivet, til sundheds- og ældreministeren
2181651_0010.png
Background
Question
and key
considerations
Has your Member State
encountered any other difficulties in
the practical application of the
provisions of this Article?
Member State response
Yes / No / To some extent.
Please elaborate, including specifying the provisions of difficulty.
Please use this space for further explanation of any of the responses above, AND / OR any other observations you would like to share related to Article 4.
1.5.4
Article 5: Reporting of ingredients and emissions
Background and
Question
key considerations
The Directive requires
manufacturers and
importers of tobacco
Has your Member State faced
any issues in requiring
manufacturers and importers to
Member State response
Yes / No / To some extent.
Please elaborate, including if there have been any issues with manufacturers or importers informing about modifications of the composition of a product.
9
10
SUU, Alm.del - 2019-20 - Endeligt svar på spørgsmål 804: Spm. om oversendelse af det spørgeskema, som EU-Kommissionen har sendt til medlemsstaterne med henblik på en evaluering af tobaksvaredirektivet, til sundheds- og ældreministeren
2181651_0011.png
products to submit to
competent authorities
certain information
concerning the
ingredients and emissions
of tobacco products.
There is an overall lack of
evidence of how this
provision is being
implemented by different
Member States.
submit the required information
in Article 5(1), the statement of
reasoning in Article 5(2), or the
toxicological data in Article
5(3)?
Has your Member State faced
Yes / No / To some extent.
any issues in making submitted
Please elaborate.
information publicly available on
a website (Article 5(4))? E.g.
Please provide a link to the publicly available list.
have there been issues with
economic operators requesting
information not be published
due to trade secrets?
Do you know if consumers
make use of the public
information? In what ways / for
what purpose?
Has your Member State faced
any issues with processing and
assessment of submitted
product information?
How has your Member State
reacted to incorrect or
insufficient submissions,
including insufficient data?
Has your Member State faced
any issues in requiring and
assessing manufacturers and
importers to submit the studies
required by Article 5(6)?
Has your Member State faced
any issues in ensuring that the
Commission and other Member
States have access to this
information (Article 5(7))?
Has your Member State used
information made available by
Yes / No.
Please elaborate.
Yes / No / To some extent.
Please elaborate, for example any difficulties with scientific capacity to understand and assess data.
Please elaborate, including the actions and follow-up undertaken
Yes / No / To some extent.
Please elaborate.
Yes / No / To some extent.
Please elaborate.
Yes / No.
If no: are you considering it? Why or why not?
10
11
SUU, Alm.del - 2019-20 - Endeligt svar på spørgsmål 804: Spm. om oversendelse af det spørgeskema, som EU-Kommissionen har sendt til medlemsstaterne med henblik på en evaluering af tobaksvaredirektivet, til sundheds- og ældreministeren
2181651_0012.png
other Member States for the
purposes of applying this
Directive (Article 5(7))?
Do you consider that the EU-
CEG system works effectively?
Would any further
developments be required to
improve its functioning?
What would be the effects on
your work of a possible
European Union database
containing information on
tobacco products, including
ingredients?
Yes / No / To some extent.
Please elaborate.
Please elaborate, including possible benefits and difficulties with an EU-wide system.
Since the Directive came into
Please elaborate.
force, how many times has your
Member State taken actions
(such as product modification,
product withdrawal, fines, or
other punitive measures)
against manufacturers or
importers due to non-
compliance related to reporting
of ingredients and emissions?
Has your Member State
encountered any other
difficulties in the practical
application of the provisions of
this Article?
Yes / No / To some extent.
Please elaborate, including specifying the provisions of difficulty.
Please use this space for further explanation of any of the responses above, AND / OR any other observations you would like to share related to Article 5.
11
12
SUU, Alm.del - 2019-20 - Endeligt svar på spørgsmål 804: Spm. om oversendelse af det spørgeskema, som EU-Kommissionen har sendt til medlemsstaterne med henblik på en evaluering af tobaksvaredirektivet, til sundheds- og ældreministeren
2181651_0013.png
Please use this space for further explanation of any of the responses above, AND / OR any other observations you would like to share related to Article 5.
1.5.5
Article 6: Priority list of additives and enhanced reporting obligations
Question
Member State response
Background and
key
considerations
The Directive requires
enhanced reporting
obligations for certain
additives contained in
cigarettes and roll-your-
own tobacco that are
included in a priority list.
In addition, Member
States shall require
manufacturers and
importers to carry out
comprehensive studies
Has your Member State faced
any issues in requiring
manufacturers and importers to
carry out the comprehensive
studies required in Article 6(2)?
Has your Member State
assessed reports submitted by
manufacturers or importers to
create the reports required in
Article 6(4)?
Yes / No / To some extent.
Please elaborate.
Yes / No / To some extent.
Please elaborate, including on possible peer-review by a scientific body
If no: are you considering it? Why or why not?
Since the publication of the
Yes / No / Considered.
priority list of additives, has your
Please elaborate
Member State taken regulatory
action on any of the ingredients
identified? Is your Member
12
13
SUU, Alm.del - 2019-20 - Endeligt svar på spørgsmål 804: Spm. om oversendelse af det spørgeskema, som EU-Kommissionen har sendt til medlemsstaterne med henblik på en evaluering af tobaksvaredirektivet, til sundheds- og ældreministeren
2181651_0014.png
and to establish a report
on the results of these
studies.
Evidence is needed to
understand whether this
provision is being
implemented and how
MS are implementing it.
State
intending
on taking
regulatory actions of this type?
Has your Member State
charged manufactures and
importers proportionate fees for
peer reviews of their reports
(Article 6(4))?
Yes / No.
If no: are you considering it? Why or why not?
Since the Directive came into
Please elaborate.
force, how many times has your
Member State taken actions
(such as product modification,
product withdrawal, fines, or
other punitive measures)
against manufacturers or
importers due to non-
compliance related to additives
and reporting?
Has your Member State
encountered any other
difficulties in the practical
application of the provisions of
this Article?
Yes / No / To some extent.
Please elaborate, including specifying the provisions of difficulty.
Please use this space for further explanation of any of the responses above, AND / OR any other observations you would like to share related to Article 6.
13
14
SUU, Alm.del - 2019-20 - Endeligt svar på spørgsmål 804: Spm. om oversendelse af det spørgeskema, som EU-Kommissionen har sendt til medlemsstaterne med henblik på en evaluering af tobaksvaredirektivet, til sundheds- og ældreministeren
2181651_0015.png
1.5.6
Article 7: Regulation of ingredients
Member State response
Yes / No / To some extent.
Please elaborate.
Background and
Question
key considerations
The Directive requires that
tobacco product with
characterising flavours be
prohibited. It also requires
independent advisory
panels to assist the
Commission with
determining the
characterising flavours
requirements.
Tobacco products with
Has your Member State faced
any issues in prohibiting the
placing on the market tobacco
products with a characterising
flavour (Article 7(1))?
Has your Member State faced
any issues in prohibiting the
placing on the market tobacco
products containing the
additives listed in Article 7(6)
(vitamins, caffeine, taurine,
etc)?
Yes / No / To some extent.
Please elaborate on the practical implementation.
Have you further detailed additives covered by this article?
Has your Member State
Yes / No/Under consideration
prohibited any products
Please list the products, if yes.
certain additives are also
following scientific evidence of
If yes, did you notify the Commission of all products?
prohibited.
their containing additives in
These provisions only apply
quantities that increase the toxic
or addictive effect, or the CMR
to certain products, and it is
properties at the stage of
important to understand
consumption to a significant or
how these bans operate
measurable degree (Article
7(9))?
differently in Member
States.
Has your Member State
encountered any other
difficulties in the practical
application of the provisions of
this Article?
Yes / No / To some extent.
Please elaborate, including specifying the provisions of difficulty.
Please use this space for further explanation of any of the responses above, AND / OR any other observations you would like to share related to Article 7.
14
15
SUU, Alm.del - 2019-20 - Endeligt svar på spørgsmål 804: Spm. om oversendelse af det spørgeskema, som EU-Kommissionen har sendt til medlemsstaterne med henblik på en evaluering af tobaksvaredirektivet, til sundheds- og ældreministeren
2181651_0016.png
Please use this space for further explanation of any of the responses above, AND / OR any other observations you would like to share related to Article 7.
For example, does the current system of listing
prohibited
additives work well, or would you prefer a list with
permitted
products or additives?
1.5.7
Articles 8-14: Labelling and Packaging
Article 8: General provisions
Article 9: General warnings and information messages on tobacco products for smoking
Article 10: Combined health warnings for tobacco products for smoking
Article 11: Labelling of tobacco products for smoking other than cigarettes, roll-your-own tobacco and waterpipe tobacco
Article 12: Labelling of smokeless tobacco products
Article 13: Product presentation
Article 14: Appearance and content of unit packets
Background and
Question
key considerations
Has your Member State faced
This Directive includes
any issues in implementing the
requirements for
provisions concerning general
mandatory health warning
warnings and information
labels and packaging of
messages on tobacco products
tobacco and related
for smoking (Articles 8 & 9)?
products. These
Has your Member State faced
requirements refer to the
any issues in implementing the
use of combined health
provisions concerning combined
warnings consisting of a
health warnings for tobacco
picture and a text,
products for smoking (Article
information on cessation
10), including the minimum
Member State response
Yes / No / To some extent.
Please elaborate.
Yes / No / To some extent.
Please elaborate.
15
16
SUU, Alm.del - 2019-20 - Endeligt svar på spørgsmål 804: Spm. om oversendelse af det spørgeskema, som EU-Kommissionen har sendt til medlemsstaterne med henblik på en evaluering af tobaksvaredirektivet, til sundheds- og ældreministeren
2181651_0017.png
Background and
Question
key considerations
services and promotional
elements in and on unit
packets.
dimension of warnings (Art.
10(1))?
Has your Member State
ensured that the provisions for
combined health warning were
properly implemented on
packages with bevelled edges
(see recital 28)? Which action
was taken if not?
Member State response
We want to understand to
what extent are general
provisions on labelling
and packaging being
implemented and if
Member States are facing
any issues implementing
Has your Member States
received any claims/complaints
any of the provisions
concerning the content or
outlined in this section.
persons depicted on health
warnings?
Yes / No / To some extent.
Please describe how you have addressed the issue.
Yes / No.
Please elaborate on the type of those claims and how you addressed them.
Has your Member State faced
Yes / No / To some extent.
any issues in implementing the
Please elaborate.
provisions of Article 9(3)
concerning the minimum
dimensions of health warnings
on the lateral surfaces of cuboid
packets such as
slim/flat/shoulder-hinged lid-
packs (taking into account the
guidance provided by the
Commission).
Has your Member State
Yes / No.
exempted any tobacco products
If no: are you considering it? Why or why not?
for smoking other than
If yes, please elaborate on the exempt products and any benefits or disadvantages.
cigarettes, roll-your-own
tobacco and waterpipe tobacco
from the obligations to carry the
information message ‘Tobacco
smoke contains over 70
substances known to cause
cancer’ (Article 11(1))?
16
17
SUU, Alm.del - 2019-20 - Endeligt svar på spørgsmål 804: Spm. om oversendelse af det spørgeskema, som EU-Kommissionen har sendt til medlemsstaterne med henblik på en evaluering af tobaksvaredirektivet, til sundheds- og ældreministeren
2181651_0018.png
Background and
Question
key considerations
Member State response
Has your Member State
Yes / No.
exempted any tobacco products
If no: are you considering it? Why or why not?
for smoking other than
If yes, please elaborate on the exempted products and any benefits or disadvantages.
cigarettes, roll-your-own
tobacco and waterpipe tobacco
from the obligations to carry
combined health warnings
(Article 11(1))?
If your Member State has
exempted products in this way,
has it faced any issues in
implementing the alternative
labels described in Article 11?
Has your Member State faced
any issues in implementing the
provisions concerning labelling
of smokeless tobacco products
(Article 12)?
Yes / No / To some extent.
Please elaborate.
Yes / No / To some extent.
Please elaborate.
Has your Member State faced
Yes / No / To some extent.
any issues in interpreting and
Please elaborate and provide examples of promotional elements you have dealt with.
implementing the provisions
concerning product presentation
(Article 13), e.g. on promotional
elements?
Has your Member State faced
any issues regarding the
minimum number of sticks per
pack or any of the other
provisions listed in Article 14
(e.g. for RYO, material/opening
of pack, etc.)
Yes / No / To some extent.
Please elaborate, including on possible further rules on pack sizes.
Since the Directive came into
Please indicate the number of actions taken per Article and elaborate on the issue(s) encountered
force, how many times has your
Member State taken actions
17
18
SUU, Alm.del - 2019-20 - Endeligt svar på spørgsmål 804: Spm. om oversendelse af det spørgeskema, som EU-Kommissionen har sendt til medlemsstaterne med henblik på en evaluering af tobaksvaredirektivet, til sundheds- og ældreministeren
2181651_0019.png
Background and
Question
key considerations
(such as product modification,
product withdrawal, fines, or
other punitive measures)
against manufacturers or
importers due to non-
compliance related to labelling
and packaging?
Should there be stricter/clearer
labelling provisions overall? Or
on any specific products
specifically?
Has your Member State
encountered any other
difficulties in the practical
application of the provisions of
Articles 8-14?
Has your Member State
encountered any other
difficulties in the practical
application of the provisions of
this Article?
Member State response
Yes / No.
Please elaborate.
Yes / No / To some extent.
Please elaborate, including specifying the provisions of difficulty.
Yes / No / To some extent.
Please elaborate, including specifying the provisions of difficulty.
Please use this space for further explanation of any of the responses above, AND / OR any other observations you would like to share related to Articles 8-14.
18
19
SUU, Alm.del - 2019-20 - Endeligt svar på spørgsmål 804: Spm. om oversendelse af det spørgeskema, som EU-Kommissionen har sendt til medlemsstaterne med henblik på en evaluering af tobaksvaredirektivet, til sundheds- og ældreministeren
2181651_0020.png
1.5.8
Articles 15-16: Traceability and security features
Member State response
Background and
Question
key considerations
This Directive introduced
an interoperable system
on traceability and security
features at Union level.
The system on traceability
and security features
requires a unique identifier
be placed on unit packs,
cartons, master cases and
shipping cases that are
either manufactured in the
EU or imported into the EU
market. All economic
Has your Member State faced
any issues in implementing the
operators from
traceability system required by
Article 15 in relation to its
manufacturing to the first
retail outlet need to track all
provisions not reflected in
Commission Implementing
packs by recording the
Regulation (EU) 2018/574, in
entry, intermediate
particular paragraphs 6
movements, and final exit
(maintenance of records of all
relevant transactions) and 7
of the packs in their
possession. We would like
(provision of equipment)?
to gather your preliminary
experiences with this
system.
Has your Member State faced
Yes / No / To some extent.
any issues in implementing the
Please elaborate.
traceability system required by
Article 15 in relation to its
provisions further specified in
Commission Implementing
Regulation (EU) 2018/574, for
example in relation to
appointment of an ID issuer and
full access to the records
created by anti-tampering
devices?
Yes / No / To some extent.
Please elaborate.
To what extent is the traceability
Please elaborate.
system (Article 15) helping to
fight the illicit trade of tobacco
products?
Has your Member State faced
any issues in implementing the
security features system
required by Article 16, for
Yes / No / To some extent.
Please elaborate.
19
20
SUU, Alm.del - 2019-20 - Endeligt svar på spørgsmål 804: Spm. om oversendelse af det spørgeskema, som EU-Kommissionen har sendt til medlemsstaterne med henblik på en evaluering af tobaksvaredirektivet, til sundheds- og ældreministeren
2181651_0021.png
Background and
Question
key considerations
example in relation to the
tamper proof marker?
To what extent is the security
features system (Article 16)
helping to fight the illicit trade of
tobacco products?
To what extent do you expect
the procedures governing the
appointment and monitoring of
ID issuers, providers of
repository services and
providers of anti-tampering
devices to provide for a
sufficient level of independence
from the tobacco industry?
Has your Member State
encountered any other
difficulties in the practical
application of the provisions of
these Articles?
Member State response
Please elaborate.
Please elaborate.
Yes / No / To some extent.
Please elaborate, including specifying the provisions of difficulty.
Please use this space for further explanation of any of the responses above, AND / OR any other observations you would like to share related to Articles 15 & 16.
1.5.9
Article 17: Tobacco for oral use
Member State response
Background and
Question
key considerations
20
21
SUU, Alm.del - 2019-20 - Endeligt svar på spørgsmål 804: Spm. om oversendelse af det spørgeskema, som EU-Kommissionen har sendt til medlemsstaterne med henblik på en evaluering af tobaksvaredirektivet, til sundheds- og ældreministeren
2181651_0022.png
Background and
Question
key considerations
The Directive prohibits
placing tobacco for oral
use on the market,
without prejudice to Article
151 of the Act of
Accession of Austria,
Finland and Sweden.
Has your Member State
encountered any difficulties in
implementing the ban on
tobacco for oral use?
Are you aware of any efforts to
circumvent the ban on tobacco
for oral use in your Member
State?
Member State response
Yes / No / To some extent.
Please elaborate.
Yes / No.
Please elaborate.
Please use this space for further explanation of any of the responses above, AND / OR any other observations you would like to share related to Article 17.
1.5.10 Article 18: Cross-border distance sales of tobacco products
Background and
Question
key considerations
The Directive allows
Member States to prohibit
cross-border distance
sales of tobacco products
to consumers. In Member
States where this is not
prohibited, retail outlets
intending to sell products
across borders must
Member State response
Has your Member State
Yes / No.
prohibited cross-border distance
If no: are you considering it? Why or why not?
sales to consumers (Article
18(1))?
For countries where cross-
border distance sales are
permitted, which retail outlets
have been registered in your
Member States (Article 18(1))?
How many retail outlets located in your Member State have registered with your competent authority?
How many retail outlets located in another Member State with consumers in your Member State have registered with your competent authority?
How many retail outlets located outside the EU with consumers in your Member State have registered with your competent authority?
21
22
SUU, Alm.del - 2019-20 - Endeligt svar på spørgsmål 804: Spm. om oversendelse af det spørgeskema, som EU-Kommissionen har sendt til medlemsstaterne med henblik på en evaluering af tobaksvaredirektivet, til sundheds- og ældreministeren
2181651_0023.png
Background and
Question
key considerations
register with the
competent authorities of
the Member State where
the retail outlet is
established and the
Member State where the
consumers are located
Retailers who sell
products across borders
are required to have an
age verification system at
sale.
Where do you publish the lists
of the retail outlets registered in
your Member State (Article
18(2))?
Member State response
Please describe where the list is published.
Please provide the list of registered retail outlets.
Has the pattern of cross-border
Yes; there have been increased cross-border distance sales / Yes; there have been reduced cross-border distance sales / No; there has been no change.
distance sales in your Member
Please elaborate.
State changed in any significant
way since the TPD was
introduced?
Are you aware of any
unregistered retail outlets
operating (selling tobacco
products) in your Member
State?
What type of age verification
systems are being used in your
Member State? Do these age
verification systems (Article
18(4)) work?
Is further action needed
regarding regulating cross-
border sales?
Has your Member State
encountered any other
difficulties in the practical
application of the provisions of
this Article?
Yes / No.
How do you monitor whether unauthorised retail outlets are active in your Member State?
If yes, do you know the origins of these retail outlets (e.g. other Member States; outside the Union)?
Yes / No / To some extent.
Please elaborate.
How do you monitor whether they work? What issues have you encountered?
Yes / No / To some extent.
Please elaborate.
Yes / No / To some extent.
Please elaborate, including specifying the provisions of difficulty.
Since the Directive came into
Please elaborate
force, how many times has your
Member State taken actions
(such as product modification,
product withdrawal, fines, or
other punitive measures)
against retailers due to non-
22
23
SUU, Alm.del - 2019-20 - Endeligt svar på spørgsmål 804: Spm. om oversendelse af det spørgeskema, som EU-Kommissionen har sendt til medlemsstaterne med henblik på en evaluering af tobaksvaredirektivet, til sundheds- og ældreministeren
2181651_0024.png
Background and
Question
key considerations
compliance related to cross-
border distance sales?
Member State response
Has your Member State
encountered any other
difficulties in the practical
application of the provisions of
this Article?
Yes / No / To some extent.
Please elaborate, including specifying the provisions of difficulty.
Please use this space for further explanation of any of the responses above, AND / OR any other observations you would like to share related to Article 18.
23
24
SUU, Alm.del - 2019-20 - Endeligt svar på spørgsmål 804: Spm. om oversendelse af det spørgeskema, som EU-Kommissionen har sendt til medlemsstaterne med henblik på en evaluering af tobaksvaredirektivet, til sundheds- og ældreministeren
2181651_0025.png
1.5.11 Article 19: Notification of novel tobacco products
Background and
Question
key considerations
Manufacturers and
importers are required to
notify Member States
about novel tobacco
products, including certain
pieces of information in
their notification. Member
States may also require
updates or additional
information, and may also
create systems for
authorising novel
products, as well as
charging manufacturers
and importers fees.
These provisions are
intended to monitor novel
products and protect
consumers’ health,
however there may have
been issues with
implementation of these
requirements, and they
may no longer be relevant
following recent market or
scientific developments.
Have there been any issues in
your Member State with
manufacturers and importers
submitting notifications about
novel tobacco products (Article
19(1))?
What types of novel products
have been notified to your
competent authority (Article
19(1))? How have these been
classified (smokeless / for
smoking)?
Have there been any issues in
your Member State with
manufacturers and importers
submitting the information
required under Article 19(1)
when notifying a novel tobacco
product?
Has your Member State
confirmed or authorised
products sooner than 6 months
before they were placed on the
market?
Has your Member State
required manufacturers or
importers of novel tobacco
products to carry out additional
tests or submit
additional/updated information
(Article 19(2))?
Has your Member State
introduced an authorisation
Member State response
Yes / No / To some extent.
Please elaborate. If there are any examples of incorrect notification, please give them here.
Please list examples of the main families/systems of notified products and their classification, for example IQOS and Heets sticks.
Yes / No / To some extent.
Please elaborate.
Yes / No.
Please elaborate with details of the type of product.
Yes / No.
If yes: how many times and for which novel products?
If no: are you considering it? Why or why not?
Please specify any issues with regards to such submissions.
Yes / No.
If no: are you considering it? Why or why not?
If yes: how does it work? Within what delay do you provide authorisations?
24
25
SUU, Alm.del - 2019-20 - Endeligt svar på spørgsmål 804: Spm. om oversendelse af det spørgeskema, som EU-Kommissionen har sendt til medlemsstaterne med henblik på en evaluering af tobaksvaredirektivet, til sundheds- og ældreministeren
2181651_0026.png
Background and
Question
key considerations
system for novel products
(Article 19(3))?
Member State response
Has your Member State
Yes / No.
prevented any submitted
Please elaborate, describing any barred products.
product entering the market
(through refusal or withdrawal of
application)?
Has your Member State
introduced any other specific
requirements related to novel
tobacco products (in addition to
the transposition of this TPD
article)?
Have TPD provisions
concerning novel tobacco
products accounted for new
market developments? Do you
consider that the TPD
appropriately addresses all
types and all aspects of
products (e.g. heat
stick/devices)?
Yes / No.
Please elaborate why, their purpose, etc.
Yes / No / To some extent.
Please elaborate.
Which of the provisions of this
Smokeless tobacco product provisions / tobacco products for smoking provisions / combination of both.
Directive apply to novel tobacco
Please elaborate.
products placed on the market
in your Member State? (Article
19(4))?
Since the Directive came into
Please elaborate.
force, how many times has your
Member State taken actions
(such as product modification,
product withdrawal, fines, or
other punitive measures)
against manufacturers or
importers due to non-
25
26
SUU, Alm.del - 2019-20 - Endeligt svar på spørgsmål 804: Spm. om oversendelse af det spørgeskema, som EU-Kommissionen har sendt til medlemsstaterne med henblik på en evaluering af tobaksvaredirektivet, til sundheds- og ældreministeren
2181651_0027.png
Background and
Question
key considerations
compliance related to
notification of novel tobacco
products?
Has your Member State
encountered any other
difficulties in the practical
application of the provisions of
this Article?
Member State response
Yes / No / To some extent.
Please elaborate, including specifying the provisions of difficulty.
Please use this space for further explanation of any of the responses above, AND / OR any other observations you would like to share related to Article 19.
Please elaborate, including specifying the provisions of difficulty/ challenges in the practical application of this Article
1.5.12 Article 20: Electronic cigarettes
Background and
Question
key considerations
Manufacturers and
importers of electronic
cigarettes and refill
containers must notify
Member States before
Have there been any issues
with manufacturers and
importers submitting
notifications about electronic
Member State response
Yes / No / To some extent.
Please elaborate. If there are any examples of incorrect notification, please give them here.
26
27
SUU, Alm.del - 2019-20 - Endeligt svar på spørgsmål 804: Spm. om oversendelse af det spørgeskema, som EU-Kommissionen har sendt til medlemsstaterne med henblik på en evaluering af tobaksvaredirektivet, til sundheds- og ældreministeren
2181651_0028.png
Background and
Question
key considerations
placing them on the
market, and the
notification must contain
certain information.
Member States are
required to ensure that
certain requirements are
met around these
products, including that
nicotine-containing liquid
does not contain nicotine
in excess of 20 mg/ml and
that electronic cigarettes
and refill containers are
child- and tamper-proof.
Unit packets of electronic
cigarettes and refill
containers also must
contain leaflets with
certain information.
cigarettes and refill containers
(Article 20(2))?
Member State response
Has your Member State
Yes / No / under consideration
requested completion of
Please elaborate.
notification information following
incorrect submission (Article
20(2))?
Has your Member State faced
any issues in objectively
assessing technical information
submitted on the various
product characteristics required
in Article 20(2)? For example,
information on nicotine doses
and uptake (Art 20(2)d)?
Has your Member State
confirmed or authorised
products sooner than 6 months
before they were placed on the
market?
Has your Member State
prevented any submitted
products from entering the
market (through refusal or
withdrawal of application)?
Has your Member State faced
any issues with quality/safety
requirements in Article 20(3)?
Yes / No.
Please elaborate, providing examples of issues with such requirements and measurement methods accepted.
Yes / No.
Please elaborate with details of the type of product/procedure.
Yes / No.
Please elaborate, describing any barred products.
Yes / No / To some extent.
Please elaborate. Is its application consistent with Article 7(6)?
Has your Member State faced
Yes / No / To some extent.
any issues in implementing the
Please elaborate.
provisions concerning leaflets in
unit packets of electronic
cigarettes (Article 20(4a))?
27
28
SUU, Alm.del - 2019-20 - Endeligt svar på spørgsmål 804: Spm. om oversendelse af det spørgeskema, som EU-Kommissionen har sendt til medlemsstaterne med henblik på en evaluering af tobaksvaredirektivet, til sundheds- og ældreministeren
2181651_0029.png
Background and
Question
key considerations
Member State response
Has your Member State faced
Yes / No / To some extent.
any issues in implementing the
Please elaborate.
provisions concerning unit
packets and outside packaging
of electronic cigarettes,
including ingredients and health
warnings (Article 20(4b and c))?
Has your Member State faced
any issues in interpreting and
implementing provisions of
Article 20(5), which prohibits
commercial communications
and advertising about e-
cigarettes?
Has your Member State faced
any issues in implementing
provisions concerning cross-
border distance sales (Article
18) specifically related to e-
cigarettes (Article 20(6))?
Yes / No / To some extent.
Please elaborate, describing challenges e.g. promotion on social media, cross border sporting events or magazines, online publications.
Yes / No / To some extent.
Please elaborate.
Has your Member State faced
Yes / No / To some extent.
any issues in requiring
Please elaborate.
manufacturers and importers to
submit the market data required
in Article 20(7)?
How has your Member State
Yes / No / To some extent.
monitored market developments
concerning electronic cigarettes
Please elaborate.
and refill containers, including
any evidence that their use is a
gateway to nicotine addiction
and ultimately traditional
tobacco consumption among
young people and non-smokers
(Article 20(7)?
28
29
SUU, Alm.del - 2019-20 - Endeligt svar på spørgsmål 804: Spm. om oversendelse af det spørgeskema, som EU-Kommissionen har sendt til medlemsstaterne med henblik på en evaluering af tobaksvaredirektivet, til sundheds- og ældreministeren
2181651_0030.png
Background and
Question
key considerations
Member State response
Has your Member State faced
Yes / No / To some extent.
any issues in making submitted
Please elaborate.
information publicly available on
Please provide a link to the publicly available list.
a website (Article 20(8))? E.g.
have there been issues with
economic operators requesting
information not be published
due to trade secrets?
Has your Member State faced
Yes / No / To some extent.
any issues in requiring
Please elaborate.
manufacturers, importers and
distributers of electronic
cigarettes and refill containers
to establish and maintain a
system for collecting information
about all of the suspected
adverse effects on human
health of these products (Article
20(9))?
Has your Member State used
Safety Gate (formerly known as
RAPEX) or the Information and
Communication System on
Market Surveillance (ICSMS) to
report on adverse effects?
Have there been any instances
in your Member State of
economic operators
withdrawing or recalling unsafe
or non-compliant products, or
taking corrective action to bring
the product into conformity with
the Directive Article 20(9))?
Has your Member State
competent authority taken any
provisional measures against
Safety Gate / ICSMS / both / none.
Please elaborate.
Yes / No.
Please elaborate, describing the products.
Yes / No.
Please elaborate, including when and how the Commission was notified.
29
30
SUU, Alm.del - 2019-20 - Endeligt svar på spørgsmål 804: Spm. om oversendelse af det spørgeskema, som EU-Kommissionen har sendt til medlemsstaterne med henblik på en evaluering af tobaksvaredirektivet, til sundheds- og ældreministeren
2181651_0031.png
Background and
Question
key considerations
manufacturers/importers of e-
cigarettes or refill containers
that comply with the
requirements of Article 20 but
could present a serious risk to
human health (Article 20(11))?
Do the TPD provisions
sufficiently cover all aspects of
emerging e-cigarette products?
Member State response
Yes / No / To some extent.
Please elaborate.
What relevant changes have occurred in the e-cigarette market since the Directive was implemented?
Since the Directive came into
Please elaborate.
force, how many times has your
Member State taken actions
(such as product modification,
product withdrawal, fines, or
other punitive measures)
against manufacturers or
importers due to non-
compliance related to e-
cigarettes and refill containers?
Has your Member State applied
Yes / No / To some extent.
similar provisions for non-
Please elaborate, including specifying the provisions of difficulty.
nicotine containing e-
cigarettes?
Has your Member State
encountered any other
difficulties in the practical
application of the provisions of
this Article?
Yes / No / To some extent.
Please elaborate, including specifying the provisions of difficulty.
Please use this space for further explanation of any of the responses above, AND / OR any other observations you would like to share related to Article 20.
30
31
SUU, Alm.del - 2019-20 - Endeligt svar på spørgsmål 804: Spm. om oversendelse af det spørgeskema, som EU-Kommissionen har sendt til medlemsstaterne med henblik på en evaluering af tobaksvaredirektivet, til sundheds- og ældreministeren
2181651_0032.png
Please use this space for further explanation of any of the responses above, AND / OR any other observations you would like to share related to Article 20.
Please elaborate, including specifying the provisions of difficulty/ challenges in the practical application of this Article
1.5.13 Article 21 & 22: Herbal products for smoking / Reporting of ingredients of herbal products for smoking
Background and
Question
key considerations
The directive provides
provisions on herbal
products for smoking,
including about health
warnings and reporting of
ingredients and
emissions.
There may be issues
faced in implementing
these requirements,
however.
Has your Member State faced
any issues in placing health
warnings on packets for herbal
products for smoking; e.g. are
there any herbal products for
smoking which do not carry the
warning (Article 21)?
Has your Member State faced
any issues in requiring
manufacturers and importers to
report the ingredients of herbal
products for smoking (Article
22(1))?
Member State response
Yes / No / To some extent.
Please elaborate.
Yes / No / To some extent.
Please elaborate.
Has your Member State faced
Yes / No / To some extent.
any issues in making submitted
Please elaborate.
information publicly available on
Please provide a link to the publicly available list.
a website (Article 22(2))? E.g.
have there been issues with
economic operators requesting
information not be published
due to trade secrets?
What types of products are on
the market in your Member
Please list the products.
31
32
SUU, Alm.del - 2019-20 - Endeligt svar på spørgsmål 804: Spm. om oversendelse af det spørgeskema, som EU-Kommissionen har sendt til medlemsstaterne med henblik på en evaluering af tobaksvaredirektivet, til sundheds- og ældreministeren
2181651_0033.png
Background and
Question
key considerations
State which are considered
herbal products for smoking?
Does your Member State apply
TPD provisions for herbal
products for smoking for certain
cannabis or marijuana products
placed legally on the market?
Member State response
Yes / No.
If yes: What additional rules and provisions apply for them beyond the TPD requirements?
Since the Directive came into
Please elaborate.
force, how many times has your
Member State taken actions
(such as product modification,
product withdrawal, fines, or
other punitive measures)
against manufacturers or
importers due to non-
compliance related to herbal
products for smoking?
Has your Member State
encountered any other
difficulties in the practical
application of the provisions of
this Article?
Yes / No / To some extent.
Please elaborate, including specifying the provisions of difficulty.
Please use this space for further explanation of any of the responses above, AND / OR any other observations you would like to share related to Articles 21 & 22.
Please elaborate, including specifying the provisions of difficulty/ challenges in the practical application of these Articles
32
33
SUU, Alm.del - 2019-20 - Endeligt svar på spørgsmål 804: Spm. om oversendelse af det spørgeskema, som EU-Kommissionen har sendt til medlemsstaterne med henblik på en evaluering af tobaksvaredirektivet, til sundheds- og ældreministeren
2181651_0034.png
1.5.14 Article 23: Cooperation and enforcement
Questions related to this Article should be addressed in parallel together with the costs-data template shared.
Background and
Question
key considerations
The Directive describes
how it should be
implemented and
enforced. There may be
issues with compliance or
enforcement.
Has your Member State faced
any difficulties in ensuring that
manufacturers and importers
provide the Commission and
Member States with complete,
correct and timely information
requested pursuant to the
Directive (Article 23(1))?
Has your Member State faced
any difficulties in enforcing the
responsibility of the
manufacturer, importer or joint
responsibility of manufacturer
and importer pursuant to Art.
23(1)?
Has your Member State faced
any issues in ensuring that
tobacco and related products
which do not comply with the
Directive and its implementing
and delegated acts are not
placed on the market?
What is your overall experience
with the enforcement of the
Directive? Do you have
adequate staffing for
enforcement activities such as
inspections?
Has your Member State faced
any court cases related to
enforcing the Directive?
Member State response
Yes / No / To some extent.
Please elaborate, including any actions your Member State has taken to enforce this obligation.
Yes / No / To some extent.
Please elaborate.
Yes / No / To some extent.
Please elaborate, including any follow up actions you have taken in this regard.
Please elaborate.
Yes / No.
Please elaborate, provide references when available.
33
34
SUU, Alm.del - 2019-20 - Endeligt svar på spørgsmål 804: Spm. om oversendelse af det spørgeskema, som EU-Kommissionen har sendt til medlemsstaterne med henblik på en evaluering af tobaksvaredirektivet, til sundheds- og ældreministeren
2181651_0035.png
Background and
Question
key considerations
What measures has your
Member State taken to ensure
that penalties for infringements
on the national provisions
transposing the Directive are
enforced?
What has been the experience
of your Member State in
cooperating with other Member
States? Have there been any
helpful mechanisms to applying
the Directive in a harmonised
way?
Member State response
Please elaborate.
Please elaborate, for example correct application, matters of interpretation, or enforcement of the Directive.
Do you consider that the
Yes/No/
Directive is applied in a conform
Please elaborate, providing examples.
way across Member States?
Please use this space for further explanation of any of the responses above, AND / OR any other observations you would like to share related to Article 23.
Please elaborate, including specifying the provisions of difficulty/ challenges in the practical application of this Article
34
35
SUU, Alm.del - 2019-20 - Endeligt svar på spørgsmål 804: Spm. om oversendelse af det spørgeskema, som EU-Kommissionen har sendt til medlemsstaterne med henblik på en evaluering af tobaksvaredirektivet, til sundheds- og ældreministeren
2181651_0036.png
1.5.15 Article 24: Free movement
Background and
Question
key considerations
Member States can but
are not required to
implement
plain/standardised
packaging of tobacco
products.
Has your Member State
implemented plain or
standardised packaging for any
products (Article 24(2))?
Member State response
Yes / No.
If no: are you considering it? Why or why not?
If yes: Please describe when and for which products you have done this.
If yes:
Please describe any
challenges you faced when
The directive also allows
introducing and implementing
Member States to prohibit
plain packaging.
certain categories of
If yes:
Were you able to
tobacco or related
products, if they justify the
observe/measure any impact of
grounds for human health
plain packaging introduction?
protection.
Please elaborate on e.g. industry reaction, public support etc.
Possible issues with e.g. removing older packs from shelves immediately?
Please elaborate on
your observations concerning prevalence/awareness/youth uptake etc. levels or possible economic impacts? Provide references when
available.
Are any categories of tobacco
Yes / No.
or related products prohibited in
If no: are you considering it? Why or why not?
your Member State (Article
If yes: Please describe which products are prohibited, and from when (also if these bans pre-dated the Directive).
24(3))?
Please use this space for further explanation of any of the responses above, AND / OR any other observations you would like to share related to Article 24.
Please elaborate, including specifying the provisions of difficulty/ challenges in the practical application of this Article
35
36